The lateral flow assay market is predicted to be worth US$ 4.3 billion in 2023, rising to US$ 6.9 billion by 2033. Throughout the forecast period, lateral flow assay sales are expected to grow at a CAGR of 4.7%.The lateral flow assay (LFA) is a well-known commercial tool in the field of on-site diagnosis because it...